UK Markets close in 6 hrs 59 mins

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
39.65+0.30 (+0.76%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5221.17B
Enterprise value 3252.18B
Trailing P/E 23.23
Forward P/E 112.55
PEG ratio (5-yr expected) 11.13
Price/sales (ttm)5.28
Price/book (mrq)3.49
Enterprise value/revenue 36.02
Enterprise value/EBITDA 716.94

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 343.08
52-week low 329.99
50-day moving average 334.97
200-day moving average 335.99

Share statistics

Avg vol (3-month) 333.1M
Avg vol (10-day) 325.3M
Shares outstanding 55.58B
Implied shares outstanding 6N/A
Float 5.57B
% held by insiders 10.04%
% held by institutions 167.60%
Shares short (14 Apr 2021) 460.89M
Short ratio (14 Apr 2021) 42.26
Short % of float (14 Apr 2021) 41.09%
Short % of shares outstanding (14 Apr 2021) 41.09%
Shares short (prior month 14 Mar 2021) 468.32M

Dividends & splits

Forward annual dividend rate 41.56
Forward annual dividend yield 43.90%
Trailing annual dividend rate 31.52
Trailing annual dividend yield 33.86%
5-year average dividend yield 43.67
Payout ratio 4122.58%
Dividend date 303 Jun 2021
Ex-dividend date 405 May 2021
Last split factor 21054:1000
Last split date 316 Nov 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 22.95%
Operating margin (ttm)24.17%

Management effectiveness

Return on assets (ttm)3.93%
Return on equity (ttm)11.06%

Income statement

Revenue (ttm)41.91B
Revenue per share (ttm)7.54
Quarterly revenue growth (yoy)-7.90%
Gross profit (ttm)33.33B
EBITDA 14.89B
Net income avi to common (ttm)6.98B
Diluted EPS (ttm)1.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.24B
Total cash per share (mrq)2.19
Total debt (mrq)41.27B
Total debt/equity (mrq)65.02
Current ratio (mrq)1.35
Book value per share (mrq)11.36

Cash flow statement

Operating cash flow (ttm)14.4B
Levered free cash flow (ttm)10.5B